[go: up one dir, main page]

AU2002365288A1 - Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases - Google Patents

Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases

Info

Publication number
AU2002365288A1
AU2002365288A1 AU2002365288A AU2002365288A AU2002365288A1 AU 2002365288 A1 AU2002365288 A1 AU 2002365288A1 AU 2002365288 A AU2002365288 A AU 2002365288A AU 2002365288 A AU2002365288 A AU 2002365288A AU 2002365288 A1 AU2002365288 A1 AU 2002365288A1
Authority
AU
Australia
Prior art keywords
treatment
reuptake inhibitor
inhibitor activity
dopamine reuptake
ischemic diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002365288A
Inventor
Lars Christian B. Ronn
Jorgen Scheel-Kruger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NTG Nordic Transport Group AS
Original Assignee
Neurosearch AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch AS filed Critical Neurosearch AS
Publication of AU2002365288A1 publication Critical patent/AU2002365288A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to the use of tropane derivatives having dopamine reuptake inhibitor activity for the treatment of diseases associated with reduced blood flow to the brain or with instances of a temporary break in blood supply to the brain, such as ischemic diseases.
AU2002365288A 2001-11-30 2002-11-28 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases Abandoned AU2002365288A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101781 2001-11-30
DKPA200101781 2001-11-30
PCT/DK2002/000796 WO2003045388A1 (en) 2001-11-30 2002-11-28 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases

Publications (1)

Publication Number Publication Date
AU2002365288A1 true AU2002365288A1 (en) 2003-06-10

Family

ID=8160868

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002365288A Abandoned AU2002365288A1 (en) 2001-11-30 2002-11-28 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases

Country Status (7)

Country Link
US (1) US7381733B2 (en)
EP (1) EP1453511B1 (en)
JP (1) JP2005511639A (en)
AT (1) ATE345135T1 (en)
AU (1) AU2002365288A1 (en)
DE (1) DE60216142T2 (en)
WO (1) WO2003045388A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003099783A2 (en) * 2002-03-28 2003-12-04 President And Fellows Of Harvard College Tropane compounds
AU2004212165B2 (en) 2003-02-12 2010-02-18 Neurosearch A/S Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
AR045141A1 (en) * 2003-07-31 2005-10-19 Neurosearch As TARTRATE SALTS OF 2- METOXIMETIL-3- (3,4-DICLOROFENIL) -8-AZABICICLO (3,2,1) OCTANO. PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USES OF THE SAME.
KR20060125805A (en) * 2003-11-18 2006-12-06 베링거 인겔하임 인터내셔날 게엠베하 Solid pharmaceutical formulation forms
DE102004004965B4 (en) 2004-01-31 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for the preparation of a 2- (ethoxymethyl) tropane derivative
CA2614833A1 (en) * 2005-07-12 2007-01-18 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising 2, 3-disubstituted tropanes for the treatment of disorders of sexual desire
GB0703998D0 (en) * 2007-03-01 2007-04-11 Glaxo Group Ltd Novel salt
US8221345B2 (en) 2007-05-30 2012-07-17 Smiths Medical Asd, Inc. Insulin pump based expert system

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179567A (en) * 1978-04-10 1979-12-18 Sterling Drug Inc. 2-Aryltropane compounds
US5272160A (en) * 1989-05-17 1993-12-21 Pfizer Inc 2-piperidino-1-alkanol derivatives as antiischemic agents
US5128118A (en) * 1990-08-09 1992-07-07 Research Triangle Institute Cocaine receptor binding ligands
US6329520B1 (en) * 1990-08-09 2001-12-11 Research Triangle Institute Cocaine receptor binding ligands
AU672052B2 (en) 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds
DK154192D0 (en) * 1992-12-23 1992-12-23 Neurosearch As HETEROCYCLIC COMPOUNDS
AU671163B2 (en) 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
AU672644B2 (en) 1992-12-23 1996-10-10 Neurosearch A/S Aryl substituted heterocyclic compounds
UA49801C2 (en) 1994-04-19 2002-10-15 Нейросерч А/С Tropane-2-aldoxime derivatives, method of its producing, pharmaceutical composition, method of curing
WO1996006081A1 (en) 1994-08-18 1996-02-29 Pfizer Inc. Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
RU2162469C2 (en) * 1995-11-02 2001-01-27 Ньюросерч А/С Condensed tropanic derivatives as neuromediator reverse capture inhibitors
SG99853A1 (en) 1996-02-22 2003-11-27 Neurosearch As Tropane-derivatives, their preparation and use
WO2001028550A1 (en) * 1999-10-15 2001-04-26 Mayo Foundation For Medical Education And Research Topical anesthetics useful for treating cancer, autoimmune diseases and ischemia
WO2002064128A1 (en) * 2001-02-15 2002-08-22 Neurosearch A/S Treatment of diseases characterized by excessive or insufficient cell death

Also Published As

Publication number Publication date
WO2003045388A1 (en) 2003-06-05
DE60216142T2 (en) 2007-09-06
US7381733B2 (en) 2008-06-03
EP1453511B1 (en) 2006-11-15
US20050020621A1 (en) 2005-01-27
DE60216142D1 (en) 2006-12-28
ATE345135T1 (en) 2006-12-15
JP2005511639A (en) 2005-04-28
EP1453511A1 (en) 2004-09-08

Similar Documents

Publication Publication Date Title
MXPA02012712A (en) N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity.
MXPA03010134A (en) Substituted cyclohexane-1,4-diamine derivatives.
NL300933I2 (en) Letermovir
IL142768A0 (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
WO2003024401A3 (en) Piperizinones as modulators of chemokine receptor activity
AU3126600A (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
UA83233C2 (en) Substituted 2-aminotetralin for the treatment of depression
MX2007000505A (en) Substituted oxindol derivatives and medicaments containing the same.
PE20030061A1 (en) 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS
MX2007000224A (en) Use of substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting.
WO2001098270A3 (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
WO2001098269A3 (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
AU2002365288A1 (en) Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
MX2007006754A (en) Indenyl derivatives and use thereof for the treatment of neurological disorders.
UA86399C2 (en) Normal;heading 1;heading 2;USE OF 2,5-DIHYDROXYBENZENESULPHONIC ACID IN THE PRODUCTION OF MEDICAMENTS FOR THE TREATMENT OF ANGIODEPENDENT DISEASES
TW200634013A (en) Quinoline derivative, its use, production and pharmaceutical agents containing the derivative
MXPA04004090A (en) Substituted 1h-quinolin-2-one compounds.
TW200639155A (en) Thiazolidinones, their production and use as pharmaceutical agents
AU2002347984A1 (en) Use of norepinephrine reuptake inhibitors for the treatment of tic disorders
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
GB0229022D0 (en) Organic Compounds
GR1004434B (en) Use of diflofenac or topically acceptable salt thereof for the treatment of burns
WO2005082862A3 (en) Benzimidazolyl derivatives as kinase inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase